VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,276 | -10.6% | 15,655 | 0.0% | 0.42% | -14.3% |
| Q2 2023 | $471,372 | -6.9% | 15,655 | 0.0% | 0.49% | -2.2% |
| Q1 2023 | $506,439 | +12.9% | 15,655 | 0.0% | 0.50% | +13.6% |
| Q4 2022 | $448,672 | +15.9% | 15,655 | -2.6% | 0.44% | +5.3% |
| Q3 2022 | $387,000 | -12.0% | 16,075 | 0.0% | 0.42% | -16.5% |
| Q2 2022 | $440,000 | -39.3% | 16,075 | -15.0% | 0.50% | -19.8% |
| Q1 2022 | $725,000 | +1.1% | 18,915 | -15.6% | 0.63% | -7.1% |
| Q4 2021 | $717,000 | +8.6% | 22,415 | 0.0% | 0.67% | +6.6% |
| Q3 2021 | $660,000 | -14.7% | 22,415 | -1.6% | 0.63% | -11.9% |
| Q2 2021 | $774,000 | -23.0% | 22,790 | -26.4% | 0.72% | -36.7% |
| Q1 2021 | $1,005,000 | -16.8% | 30,950 | -7.8% | 1.13% | -13.6% |
| Q4 2020 | $1,208,000 | -8.1% | 33,560 | 0.0% | 1.31% | -24.1% |
| Q3 2020 | $1,314,000 | +6.1% | 33,560 | -0.7% | 1.73% | +4.5% |
| Q2 2020 | $1,239,000 | +62.8% | 33,790 | +2.2% | 1.65% | +38.3% |
| Q1 2020 | $761,000 | -21.7% | 33,050 | -0.5% | 1.20% | +17.3% |
| Q4 2019 | $972,000 | +7.0% | 33,220 | -2.4% | 1.02% | +1.1% |
| Q3 2019 | $908,000 | +3.8% | 34,020 | -0.7% | 1.01% | -0.2% |
| Q2 2019 | $875,000 | +4.5% | 34,265 | -8.3% | 1.01% | +0.5% |
| Q1 2019 | $837,000 | -1.6% | 37,355 | -7.4% | 1.00% | +2.1% |
| Q4 2018 | $851,000 | -27.1% | 40,355 | -36.1% | 0.98% | -14.9% |
| Q3 2018 | $1,168,000 | -24.0% | 63,105 | -8.5% | 1.16% | -18.6% |
| Q2 2018 | $1,537,000 | -6.8% | 68,935 | -8.1% | 1.42% | -9.7% |
| Q1 2018 | $1,649,000 | -6.7% | 75,040 | -1.4% | 1.57% | -8.7% |
| Q4 2017 | $1,768,000 | -0.2% | 76,110 | -1.3% | 1.72% | -6.0% |
| Q3 2017 | $1,771,000 | +1.9% | 77,140 | -2.0% | 1.83% | +2.3% |
| Q2 2017 | $1,738,000 | -2.5% | 78,750 | +0.7% | 1.79% | +9.5% |
| Q1 2017 | $1,783,000 | +8.2% | 78,170 | -0.8% | 1.64% | +10.2% |
| Q4 2016 | $1,648,000 | -60.8% | 78,820 | -50.4% | 1.48% | -26.0% |
| Q3 2016 | $4,202,000 | +90.2% | 159,020 | +99.5% | 2.00% | -3.5% |
| Q2 2016 | $2,209,000 | – | 79,720 | – | 2.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |